InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,612.80
(
0.00%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
81.87
(
-1.20%
)
Bitcoin
62,156.77
(
-0.28%
)
Post# of 6724
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119591
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Monday, 12/13/2021 11:23:20 AM

Monday, December 13, 2021 11:23:20 AM

Post# of 6724
ABUS inks Greater-China* development deal for AB-729—$40M up-front cash:

https://finance.yahoo.com/news/arbutus-qilu-pharmaceutical-enter-exclusive-123000244.html

AB-729, an injected RNAi agent that targets HBsAg (HBV surface antigen), is a drug candidate I’ve been generally unimpressed with (e.g. #msg-164615657).

However, the most notable aspect of the above deal (IMO) is that it does not include AB-806, ABUS’ core inhibitor (#msg-167079537).

*China, Hong Kong, Macau, Taiwan.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ABUS News
More ABUS News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!